SEC Form 13F
| Report period | 2025-09-30 |
|---|---|
| Publicly available | 2025-11-15 |
| Reported value | $44,506,160 |
| Positions | 4 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Entrada Therapeutics, Inc. | TRDA | Common | $25,410,160 | 4,381,062 |
| Dyne Therapeutics, Inc. | DYN | Common | $8,632,056 | 682,376 |
| Werewolf Therapeutics, Inc. | HOWL | Common | $8,490,424 | 4,309,860 |
| Repare Therapeutics, Inc. | RPTX | Common | $1,973,520 | 1,121,318 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.